SMARCA4 and neoplasm: In four patients, longitudinal analysis of subsequent lesions highlighted an increase in mutations, like missense or splice variants in the PMS2, SMARCA4, ARID1A, AKT1, BMPR1A, and PTEN genes, suggesting tumor evolution.